- Home
- IVZ vs CHE Comparison
IVZ vs CHE Comparison
Compare IVZ & CHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVZ
- CHE
- Stock Information
- Founded
- IVZ 1935
- CHE 1970
- Country
- IVZ United States
- CHE United States
- Employees
- IVZ N/A
- CHE N/A
- Industry
- IVZ Investment Managers
- CHE Medical/Nursing Services
- Sector
- IVZ Finance
- CHE Health Care
- Exchange
- IVZ Nasdaq
- CHE Nasdaq
- Market Cap
- IVZ 9.9B
- CHE 8.0B
- IPO Year
- IVZ 1995
- CHE N/A
- Fundamental
- Price
- IVZ $22.59
- CHE $453.22
- Analyst Decision
- IVZ Hold
- CHE Strong Buy
- Analyst Count
- IVZ 16
- CHE 4
- Target Price
- IVZ $19.36
- CHE $578.50
- AVG Volume (30 Days)
- IVZ 4.0M
- CHE 201.6K
- Earning Date
- IVZ 10-21-2025
- CHE 10-28-2025
- Dividend Yield
- IVZ 3.73%
- CHE 0.53%
- EPS Growth
- IVZ N/A
- CHE N/A
- EPS
- IVZ 0.93
- CHE 19.48
- Revenue
- IVZ $6,153,100,000.00
- CHE $2,511,915,000.00
- Revenue This Year
- IVZ N/A
- CHE $5.91
- Revenue Next Year
- IVZ $9.86
- CHE $6.72
- P/E Ratio
- IVZ $24.21
- CHE $23.22
- Revenue Growth
- IVZ 5.83
- CHE 7.55
- 52 Week Low
- IVZ $11.60
- CHE $408.42
- 52 Week High
- IVZ $22.78
- CHE $623.61
- Technical
- Relative Strength Index (RSI)
- IVZ 65.06
- CHE 48.00
- Support Level
- IVZ $21.89
- CHE $449.55
- Resistance Level
- IVZ $22.73
- CHE $462.99
- Average True Range (ATR)
- IVZ 0.46
- CHE 8.74
- MACD
- IVZ -0.04
- CHE -0.22
- Stochastic Oscillator
- IVZ 85.71
- CHE 38.72
About IVZ Invesco Ltd
Invesco provides investment-management services to retail (68% of managed assets) and institutional (32%) clients. At the end of July 2025, the firm had $2.025 trillion in assets under management spread among its equity (60% of AUM), balanced (3%), fixed-income (21%), alternative investment (6%), and money market (10%) operations. Passive products account for 46% of Invesco's total AUM. Invesco's US retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside of North America, with 30% of its AUM sourced from Europe, Africa, and the Middle East (15%) and Asia (15%).
About CHE Chemed Corp
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.